Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

We recently had the privilege of attending the European Society for Medical Oncology (ESMO). With over 40,000 oncology professionals from 177 countries, ESMO stands as a global leader in oncology ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Johnson & Johnson’s (J&J) Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission (EC) as a long-term treatment for pulmonary ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people around the world. So, earlier this year, purpose consultancy Revolt launched ...

The US Food and Drug Administration (FDA) has approved IntraBio’s Aqneursa (levacetylleucine) to treat neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and paediatric ...